Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Sensorium Therapeutics is a pioneering company focused on developing breakthrough psychoactive medicines to address unmet medical needs in mental health and neurological diseases. Utilizing their…

Sensorium Therapeutics is a pioneering company focused on developing breakthrough psychoactive medicines to address unmet medical needs in mental health and neurological diseases. Utilizing their…
Stage: Clinical-stage
Lead program: SNTX-12643 (SENS-01) — FDA IND cleared for first-in-human dosing planned Q3 2025
Platform: SensAI — AI + chemistry + neuroscience mapping ~50M curated relationships
Founded: 2021
Headquarters: Boston, Massachusetts
Known total funding: USD 55,000,000
Mental health and neurological disorders (e.g., anxiety, epilepsy)
2021
Biotechnology
USD 25,000,000
Reported Series A round (~$25M) with investors including Mockingbird Capital Partners and Dolby Family Ventures (per dealroom reporting)
USD 55,000,000
Aggregated total funding amount reported
“Institutional venture investors participated, including Dolby Family Ventures, Mockingbird Capital Partners, Route 66 Ventures, Sante Ventures, CU Healthcare Innovation Fund, WPSS.bio, Hatteras Venture Partners, Mission BioCapital, Ocama Partners, Palo Santo Fund, Route 66 Ventures, The CU Healthcare Innovation Fund, re.Mind Capital”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week